232 related articles for article (PubMed ID: 18202185)
1. Neurodegeneration and neuroinflammation in cdk5/p25-inducible mice: a model for hippocampal sclerosis and neocortical degeneration.
Muyllaert D; Terwel D; Kremer A; Sennvik K; Borghgraef P; Devijver H; Dewachter I; Van Leuven F
Am J Pathol; 2008 Feb; 172(2):470-85. PubMed ID: 18202185
[TBL] [Abstract][Full Text] [Related]
2. Deregulation of cdk5 in Hippocampal sclerosis.
Sen A; Thom M; Martinian L; Jacobs T; Nikolic M; Sisodiya SM
J Neuropathol Exp Neurol; 2006 Jan; 65(1):55-66. PubMed ID: 16410749
[TBL] [Abstract][Full Text] [Related]
3. Specific inhibition of p25/Cdk5 activity by the Cdk5 inhibitory peptide reduces neurodegeneration in vivo.
Sundaram JR; Poore CP; Sulaimee NH; Pareek T; Asad AB; Rajkumar R; Cheong WF; Wenk MR; Dawe GS; Chuang KH; Pant HC; Kesavapany S
J Neurosci; 2013 Jan; 33(1):334-43. PubMed ID: 23283346
[TBL] [Abstract][Full Text] [Related]
4. Synaptic deficits are rescued in the p25/Cdk5 model of neurodegeneration by the reduction of β-secretase (BACE1).
Giusti-Rodríguez P; Gao J; Gräff J; Rei D; Soda T; Tsai LH
J Neurosci; 2011 Nov; 31(44):15751-6. PubMed ID: 22049418
[TBL] [Abstract][Full Text] [Related]
5. Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles.
Cruz JC; Tseng HC; Goldman JA; Shih H; Tsai LH
Neuron; 2003 Oct; 40(3):471-83. PubMed ID: 14642273
[TBL] [Abstract][Full Text] [Related]
6. Partial rescue of the p35-/- brain phenotype by low expression of a neuronal-specific enolase p25 transgene.
Patzke H; Maddineni U; Ayala R; Morabito M; Volker J; Dikkes P; Ahlijanian MK; Tsai LH
J Neurosci; 2003 Apr; 23(7):2769-78. PubMed ID: 12684463
[TBL] [Abstract][Full Text] [Related]
7. Involvement of aberrant cyclin-dependent kinase 5/p25 activity in experimental traumatic brain injury.
Yousuf MA; Tan C; Torres-Altoro MI; Lu FM; Plautz E; Zhang S; Takahashi M; Hernandez A; Kernie SG; Plattner F; Bibb JA
J Neurochem; 2016 Jul; 138(2):317-27. PubMed ID: 26998748
[TBL] [Abstract][Full Text] [Related]
8. Cdk5 Inhibitory Peptide Prevents Loss of Neurons and Alleviates Behavioral Changes in p25 Transgenic Mice.
Huang Y; Huang W; Huang Y; Song P; Zhang M; Zhang HT; Pan S; Hu Y
J Alzheimers Dis; 2020; 74(4):1231-1242. PubMed ID: 32144987
[TBL] [Abstract][Full Text] [Related]
9. Cdk5/p25-induced cytosolic PLA2-mediated lysophosphatidylcholine production regulates neuroinflammation and triggers neurodegeneration.
Sundaram JR; Chan ES; Poore CP; Pareek TK; Cheong WF; Shui G; Tang N; Low CM; Wenk MR; Kesavapany S
J Neurosci; 2012 Jan; 32(3):1020-34. PubMed ID: 22262900
[TBL] [Abstract][Full Text] [Related]
10. AAV9-Mediated Cdk5 Inhibitory Peptide Reduces Hyperphosphorylated Tau and Inflammation and Ameliorates Behavioral Changes Caused by Overexpression of p25 in the Brain.
Xu M; Huang Y; Song P; Huang Y; Huang W; Zhang HT; Hu Y
J Alzheimers Dis; 2019; 70(2):573-585. PubMed ID: 31256130
[TBL] [Abstract][Full Text] [Related]
11. Peptides derived from Cdk5 activator p35, specifically inhibit deregulated activity of Cdk5.
Kesavapany S; Zheng YL; Amin N; Pant HC
Biotechnol J; 2007 Aug; 2(8):978-87. PubMed ID: 17526058
[TBL] [Abstract][Full Text] [Related]
12. CDK5 activator protein p25 preferentially binds and activates GSK3β.
Chow HM; Guo D; Zhou JC; Zhang GY; Li HF; Herrup K; Zhang J
Proc Natl Acad Sci U S A; 2014 Nov; 111(45):E4887-95. PubMed ID: 25331900
[TBL] [Abstract][Full Text] [Related]
13. Neurodegeneration-Like Pathological and Behavioral Changes in an AAV9-Mediated p25 Overexpression Mouse Model.
Zhou X; Huang J; Pan S; Xu M; He R; Ji Z; Hu Y
J Alzheimers Dis; 2016 May; 53(3):843-55. PubMed ID: 27258419
[TBL] [Abstract][Full Text] [Related]
14. p10, the N-terminal domain of p35, protects against CDK5/p25-induced neurotoxicity.
Zhang L; Liu W; Szumlinski KK; Lew J
Proc Natl Acad Sci U S A; 2012 Dec; 109(49):20041-6. PubMed ID: 23151508
[TBL] [Abstract][Full Text] [Related]
15. Involvement of cyclin dependent kinase5 activator p25 on tau phosphorylation in mouse brain.
Takashima A; Murayama M; Yasutake K; Takahashi H; Yokoyama M; Ishiguro K
Neurosci Lett; 2001 Jun; 306(1-2):37-40. PubMed ID: 11403952
[TBL] [Abstract][Full Text] [Related]
16. Effects of cyclin-dependent kinase-5 activity on apoptosis and tau phosphorylation in immortalized mouse brain cortical cells.
Shelton SB; Krishnamurthy P; Johnson GV
J Neurosci Res; 2004 Apr; 76(1):110-20. PubMed ID: 15048935
[TBL] [Abstract][Full Text] [Related]
17. Cyclin-dependent kinase 5 activator p35 over-expression and amyloid beta synergism increase apoptosis in cultured neuronal cells.
Utreras E; Maccioni R; González-Billault C
Neuroscience; 2009 Jul; 161(4):978-87. PubMed ID: 19362124
[TBL] [Abstract][Full Text] [Related]
18. AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576.
Otth C; Concha II; Arendt T; Stieler J; Schliebs R; González-Billault C; Maccioni RB
J Alzheimers Dis; 2002 Oct; 4(5):417-30. PubMed ID: 12446973
[TBL] [Abstract][Full Text] [Related]
19. The role of CDK5/P25 formation/inhibition in neurodegeneration.
Camins A; Verdaguer E; Folch J; Canudas AM; Pallàs M
Drug News Perspect; 2006 Oct; 19(8):453-60. PubMed ID: 17160145
[TBL] [Abstract][Full Text] [Related]
20. Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration.
Patrick GN; Zukerberg L; Nikolic M; de la Monte S; Dikkes P; Tsai LH
Nature; 1999 Dec; 402(6762):615-22. PubMed ID: 10604467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
